These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22558478)

  • 1. The histopathological spectrum of human meningiomas.
    Backer-Grøndahl T; Moen BH; Torp SH
    Int J Clin Exp Pathol; 2012; 5(3):231-42. PubMed ID: 22558478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of meningioma grading: a 10-year retrospective audit.
    Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
    Biczok A; Kraus T; Suchorska B; Terpolilli NA; Thorsteinsdottir J; Giese A; Tonn JC; Schichor C
    J Neurooncol; 2018 Sep; 139(3):671-678. PubMed ID: 29808339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiopathological classification of dural tail sign of meningiomas.
    Qi ST; Liu Y; Pan J; Chotai S; Fang LX
    J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO classification of meningiomas-A single institutional experience.
    Salami AA; Okunlola AI; Ajani MA; Onakpoma F
    Neurochirurgie; 2021 Apr; 67(2):119-124. PubMed ID: 33144180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
    Delgado-López PD; Corrales-García EM
    Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
    Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
    Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
    Simon M; Boström J; Koch P; Schramm J
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
    Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
    Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas.
    Ehret F; Perez E; Teichmann D; Meier S; Geiler C; Zeus C; Franke H; Roohani S; Wasilewski D; Onken J; Vajkoczy P; Schweizer L; Kaul D; Capper D
    Acta Neuropathol Commun; 2024 May; 12(1):74. PubMed ID: 38720399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
    Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
    Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
    Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
    Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological classification and molecular genetics of meningiomas.
    Mawrin C; Perry A
    J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-parametric qualitative and quantitative MRI assessment as predictor of histological grading in previously treated meningiomas.
    Sacco S; Ballati F; Gaetani C; Lomoro P; Farina LM; Bacila A; Imparato S; Paganelli C; Buizza G; Iannalfi A; Baroni G; Valvo F; Bastianello S; Preda L
    Neuroradiology; 2020 Nov; 62(11):1441-1449. PubMed ID: 32583368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.